Category Medicine and Healthcare
Press Release
Interactive Strength Inc. (Nasdaq:TRNR) Updates Shareholders on 2025 Progress To Date
Acquisitions are On Track and Progressing From Signing to Closing; Guidance of $65M+ In Pro Forma Revenues Remains In Place TRNR Expects to Provide Positive Update on Sportstech Q1 2025 Performance in May 2025 Read More
Press Release
Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates
Reports first quarter revenues of $0.1 billion, GAAP net loss of $(1.0) billion and GAAP EPS of $(2.52) Reiterates 2025 expected revenue range of $1.5 to $2.5 billion and 2025 year-end cash balance of approximately $6 billion Announces reduction of $1.4 to $1.7 billion in estimated GAAP operating costs by 2027 Advancing up to 10 products toward approval, including multiple oncology candidates Read More
Press Release
Mentavi Health to Present Study Validating Its Online Assessment for Diagnosing Adult ADHD at Major International Conference
Mentavi, a national leader in online mental health testing, will attend the 10th World Congress on ADHD and present a first-ever study comparing the accuracy and validity of an online asynchronous assessment for diagnosing ADHD in adults with the current standard of care, a clinical interview. Read More
Press Release
DEA Unconstitutional Marijuana Hearing - MMJ to File Emergency Injunction and Suit for Irreparable Harm
“We are not just challenging DEA policy, we are defending the Constitution said Duane Boise, CEO of MMJ BioPharma Cultivation. The DEA cannot sidestep Supreme Court precedent and force us into a hearing. The agency is running a closed loop of power, Boise added, they investigate, prosecute, judge and override all in-house. That’s not justice, that’s a rigged game.” Read More
Press Release
Interactive Strength Inc. (Nasdaq:TRNR) Provides Shareholder Update on 2025 Developments
Company Confirms Both Acquisitions are On Track and Progressing From Signing to Closing, Reiterates Guidance of $65M+ Pro Forma Revenues TRNR to Provide Positive Update on Sporstech Q1 2025 Performance in May 2025 Read More
Press Release
Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease Progression in Intestinal Failure Patients
Read More
Press Release
REMINDER: Jaguar Health Hosting April 30 Investor Webcast to Present Initial Results from Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF)
The webcast will review the MVID and SBS-IF patient experience, the impact of crofelemer on disease progression and quality of life in MVID and SBS-IF, and possible expedited regulatory pathways for crofelemer for MVID; Click here to register There are currently no approved drug treatments for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid management This data was presented at the Annual ELITE PED-GI Congress by Dr. Mohamad Miqdady, a recognized leader in pediatric gastroenterology and the primary investigator for this study Read More
Press Release
Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application
- Rigorous humanized mouse model enhances credibility and translatability of results - Key preclinical data to support FDA Orphan Drug Application - In vitro success signals potential for exosome-based therapy breakthrough Read More
Press Release
Sound Physicians Launches Sound Practice Solutions - a Groundbreaking Approach to Hospital Performance & Revenue Optimization
New offering empowers hospitals to enhance clinical excellence, streamline operations, and helps secure sustainable financial growth without disrupting existing clinician employment models. Read More
Press Release
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
Patient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business Days Critical Milestone Achieved for Multi-Center Clinical Trial in India with Strategic Partner Shalby Hospitals for the mBȏs TKA System Read More
Press Release
Jaguar Health to Present Initial Results from the Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) During an April 30 Investor Webcast
The webcast will review the MVID and SBS-IF patient experience, the impact of crofelemer on disease progression and quality of life in MVID and SBS-IF, and possible expedited regulatory pathways for crofelemer for MVID; Click here to register There are currently no approved drug treatments for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid management This data was presented at the Annual ELITE PED-GI Congress by Dr. Mohamad Miqdady, a recognized leader in pediatric gastroenterology and the primary investigator for this study Read More
Press Release
World Class Health Announces $10M Funding Round to Transform Care Access
As the largest lever to lower health care costs for self-insured employers, World Class Health will use the new funding to continue expanding the industry's most expansive U.S. and global Centers of Excellence network. Read More
Press Release
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
The platform will be showcased at the American Academy of Neurological Surgeons Annual Meeting in Boston on April 25-28, 2025. Read More
Press Release
